{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T05:49:06.335651+00:00","published_at":"2026-10-17T04:48:44.278847+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:fqkef1qxve95","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-31","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:bastiaan-van-der-baan","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:c00343a8f76ec5e404d797e539e566e1c148387aa6f1b57a45e27da724cb747a"],"summary":"Bastiaan van der Baan executive of LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qc4unx1ceozoh","event_type":"CEO_CHANGED","effective_at":"2026-03-31","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:geordan-pursglove","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:80f748c39139c52eaf7f492c8d149752b3d9bc3ddf6481a8bf6a52b8bd65fd33"],"summary":"Geordan Pursglove executive of LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nxf9rj1jxyekh","event_type":"CFO_CHANGED","effective_at":"2026-03-31","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:peter-stazzone","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:0d59058a71148cb37bb9d44d283db23bc632ad027902cdab0023be552e3b1825"],"summary":"Peter Stazzone executive of LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:eghevhggp6cp","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:geordan-pursglove","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3"],"summary":"Geordan Pursglove seat on LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:piun7g1n80e2e","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:guy-primus","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3"],"summary":"Guy Primus seat on LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fxmewn19w25i3","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:jason-sawyer","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3"],"summary":"Jason Sawyer seat on LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1l0rfte1rkgpyw","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:lourdes-felix-2","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3"],"summary":"Lourdes Felix seat on LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15lk41u1ia61uy","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:committee:lixte-biotechnology-holdings-inc:audit-compensation","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3"],"summary":"Audit; Compensation committee of LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vlkbpm19w8qe4","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:guy-primus","alpha:committee:lixte-biotechnology-holdings-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3"],"summary":"Guy Primus member of Audit; Compensation, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1seykzvg9jvur","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:committee:lixte-biotechnology-holdings-inc:audit-compensation-chair","alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3"],"summary":"Audit; Compensation · Chair committee of LIXTE BIOTECHNOLOGY HOLDINGS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1kommbf1qjc0ax","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:48:44.278847+00:00","subject_ids":["alpha:person:jason-sawyer","alpha:committee:lixte-biotechnology-holdings-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3"],"summary":"Jason Sawyer member of Audit; Compensation · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:5","subject_id":"alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:geordan-pursglove","object_label":"Geordan Pursglove","object_source_name_forms":[],"value":"Geordan Pursglove: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:geordan-pursglove","name":"Geordan Pursglove"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:48:44.278847+00:00","sources":[{"id":"alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LIXTE BIOTECHNOLOGY HOLDINGS, INC. DEF 14A 2025-10-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315225019697/formdef14a.htm","source_date":"2025-10-27","retrieved_at":"2026-04-28T22:29:00.951+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-27","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:48:44.278847+00:00","reviewed_at":"2026-10-17T04:48:44.278847+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:6","subject_id":"alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:guy-primus","object_label":"Guy Primus","object_source_name_forms":[],"value":"Guy Primus: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:guy-primus","name":"Guy Primus"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:48:44.278847+00:00","sources":[{"id":"alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LIXTE BIOTECHNOLOGY HOLDINGS, INC. DEF 14A 2025-10-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315225019697/formdef14a.htm","source_date":"2025-10-27","retrieved_at":"2026-04-28T22:29:00.951+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-27","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:48:44.278847+00:00","reviewed_at":"2026-10-17T04:48:44.278847+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:7","subject_id":"alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jason-sawyer","object_label":"Jason Sawyer","object_source_name_forms":[],"value":"Jason Sawyer: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jason-sawyer","name":"Jason Sawyer"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:48:44.278847+00:00","sources":[{"id":"alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LIXTE BIOTECHNOLOGY HOLDINGS, INC. DEF 14A 2025-10-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315225019697/formdef14a.htm","source_date":"2025-10-27","retrieved_at":"2026-04-28T22:29:00.951+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-27","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:48:44.278847+00:00","reviewed_at":"2026-10-17T04:48:44.278847+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:8","subject_id":"alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lourdes-felix-2","object_label":"Lourdes Felix","object_source_name_forms":[],"value":"Lourdes Felix: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lourdes-felix-2","name":"Lourdes Felix"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:48:44.278847+00:00","sources":[{"id":"alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LIXTE BIOTECHNOLOGY HOLDINGS, INC. DEF 14A 2025-10-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315225019697/formdef14a.htm","source_date":"2025-10-27","retrieved_at":"2026-04-28T22:29:00.951+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-27","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:48:44.278847+00:00","reviewed_at":"2026-10-17T04:48:44.278847+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:9","subject_id":"alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:bastiaan-van-der-baan","object_label":"Bastiaan van der Baan","object_source_name_forms":[],"value":"Bastiaan van der Baan: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:bastiaan-van-der-baan","name":"Bastiaan van der Baan"},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-17T04:48:44.278847+00:00","sources":[{"id":"alpha:projection-evidence:document:c00343a8f76ec5e404d797e539e566e1c148387aa6f1b57a45e27da724cb747a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LIXT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226014052/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T04:55:25.566473+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-17T04:48:44.278847+00:00","reviewed_at":"2026-10-17T04:48:44.278847+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:10","subject_id":"alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:geordan-pursglove","object_label":"Geordan Pursglove","object_source_name_forms":[],"value":"Geordan Pursglove: President, Chief Executive Officer, and Chairman of the Board of Directors","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:geordan-pursglove","name":"Geordan Pursglove"},"title":"President, Chief Executive Officer, and Chairman of the Board of Directors","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-17T04:48:44.278847+00:00","sources":[{"id":"alpha:projection-evidence:document:80f748c39139c52eaf7f492c8d149752b3d9bc3ddf6481a8bf6a52b8bd65fd33","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LIXT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226014052/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T04:55:25.049331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-17T04:48:44.278847+00:00","reviewed_at":"2026-10-17T04:48:44.278847+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4:leadership_role:11","subject_id":"alpha:company:e40490b8-bfb7-4ef6-9733-ccfd50156ea4","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:peter-stazzone","object_label":"Peter Stazzone","object_source_name_forms":[],"value":"Peter Stazzone: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:peter-stazzone","name":"Peter Stazzone"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-17T04:48:44.278847+00:00","sources":[{"id":"alpha:projection-evidence:document:0d59058a71148cb37bb9d44d283db23bc632ad027902cdab0023be552e3b1825","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LIXT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226014052/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T04:55:26.083563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-17T04:48:44.278847+00:00","reviewed_at":"2026-10-17T04:48:44.278847+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:2dfc42c6a6b889c3ed4da504712ebbc5d92c693e6308610e4da5febeba7edaf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LIXTE BIOTECHNOLOGY HOLDINGS, INC. DEF 14A 2025-10-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315225019697/formdef14a.htm","source_date":"2025-10-27","retrieved_at":"2026-04-28T22:29:00.951+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c00343a8f76ec5e404d797e539e566e1c148387aa6f1b57a45e27da724cb747a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LIXT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226014052/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T04:55:25.566473+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:80f748c39139c52eaf7f492c8d149752b3d9bc3ddf6481a8bf6a52b8bd65fd33","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LIXT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226014052/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T04:55:25.049331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0d59058a71148cb37bb9d44d283db23bc632ad027902cdab0023be552e3b1825","identity_scope":"source_document_reference","source_type":"sec_filing","title":"LIXT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226014052/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T04:55:26.083563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.827,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.845,"cross_source_agreement":0.75,"temporal_completeness":0.5},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:48:44.278847+00:00","observed_at":"2026-10-17T04:48:44.278847+00:00","reviewed_at":"2026-10-17T04:48:44.278847+00:00","verified_at":"2026-10-17T04:48:44.278847+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/lixte-biotechnology-holdings-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/lixte-biotechnology-holdings-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}